Clinical Trial Update: Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist（Diphenhydramine）in Advanced and Metastatic Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating tislelizumab in combination with platinum-based chemotherapy for advanced and metastatic non-small cell lung cancer, using diphenhydr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Diphenhydramine (diphenhydramine)
• Platinum-based chemotherapy (unspecified)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Advanced and Metastatic NSCLC | Phase 3 | Status: NOT_YET_RECRUITING